CSL Limited Company Description
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants.
This segment also offers therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas.
The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments.
The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology.
It also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
| Country | Australia |
| Founded | 1916 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 29,904 |
| CEO | Gordon Naylor |
Contact Details
Address: 655 Elizabeth Street Melbourne, VIC 3000 Australia | |
| Phone | 61 3 9389 1911 |
| Website | csl.com |
Stock Details
| Ticker Symbol | CSLLY |
| Exchange | OTCMKTS |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| ISIN Number | US12637N2045 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Gordon Naylor BEng (Hons), C.P.A., DipCompSc, M.B.A. | Interim Chief Executive Officer, MD and Director |
| Andy Schmeltz | Chief Commercial Officer |
| Ken Lim | Chief Financial Officer |
| Dr. Mary Oates Ph.D. | Executive Vice President and Chief Operating Officer |
| Gregory Boss B.S., BS(Hons), J.D. | Executive Vice President of Legal and Group General Counsel |
| Roanne Parry | Chief Human Resources Officer |
| Dr. William Mezzanotte M.D., M.P.H. | Chief Medical Officer, Executive Vice President and Head of Research and Development |
| Mark Hill B.A., M.B.A. | Chief Digital Information Officer and Executive Vice President |
| Deirdre BeVard | Senior Vice President of Research and Development Strategic Operations |
| Herve Gisserot | Executive Vice President of Business Development and Enterprise Alliance Management |